Adenoviral-based COVID-19 vaccines may be associated with increased incidence of myocardial infarction and pulmonary embolism among people aged younger than 75 years,...
Previous or pre-existing cardiovascular conditions are associated with increased COVID-19 severity in pediatric patients. These findings were published in JAMA Network Open.
